
|Articles|October 7, 2010
Highlights of dry eye Phase 2 clinical study revealed
ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina: Inadvertent anti-VEGF interval increases during the COVID-19 pandemic
2
FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen
3
Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis
4








































